Medication info
Vistar Tablets 10/20mg

Vistar Tablets 10/20mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White to off-white, bilaterally convex rectangular tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201601009 · Approved 2016.02.24 · Insurance code 650303450

Summary

Main use
Improves hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, the recommended treatment goal, and the patient’s response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of 4 weeks or longer and adjust the dose accordingly. Due to an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be given only to patients who have taken 10/80 mg of this medicine for more than 12 months without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not effective. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with impaired liver function). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration in older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improves hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication helps lower high cholesterol and LDL-cholesterol levels in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial hypercholesterolemia, while also reducing ApoB protein and triglycerides and increasing HDL-cholesterol. It can be used alone or in conjunction with other lipid-lowering therapies to effectively manage total cholesterol and LDL-cholesterol levels in patients with homozygous familial hypercholesterolemia. This medication should be used in conjunction with an appropriate dietary regimen and is administered when there is a lack of response to dietary measures or non-drug interventions. It's essential to check for dyslipidemia due to other causes before usage and to treat as necessary. During treatment, periodic monitoring of total cholesterol, LDL and HDL-cholesterol, and triglyceride levels is recommended to ensure appropriate control. Overall, this medication is used to improve blood lipid levels and reduce the risk of cardiovascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, the recommended treatment goal, and the patient’s response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of 4 weeks or longer and adjust the dose accordingly. Due to an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be given only to patients who have taken 10/80 mg of this medicine for more than 12 months without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not effective. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with impaired liver function). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration in older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication may cause serious muscle-related side effects, such as myopathy and rhabdomyolysis, so if muscle pain or weakness occurs, you must consult a doctor immediately. This medication should not be used by individuals who are allergic to its components, those with severely impaired liver function, and those who are pregnant or breastfeeding. Particularly, this medication may harm the fetus during pregnancy, so women planning to become pregnant or who may be pregnant should consult a doctor before taking it, and should immediately discontinue use if pregnancy is confirmed. The risk of muscle damage significantly increases when this medication is used with potent CYP3A4 inhibitors, including certain antifungals, antibiotics, and antivirals, so these should not be taken together. Additionally, this medication should not be used in combination with certain other medications, such as gemfibrozil, cyclosporine, or danazol; consult a doctor for appropriate alternative medications if necessary. This medication contains lactose, so it should not be taken by patients with lactose intolerance or related genetic disorders. Elderly patients, those with impaired kidney function, and those with hypothyroidism should be monitored closely due to increased risk of myopathy. To reduce the risk of myopathy, regular blood tests to check muscle enzyme levels are recommended during the course of this medication. The risk of myopathy may increase if other interacting medications are taken, so always consult a doctor or pharmacist when starting or stopping any new medication. If unexplained muscle pain, tenderness, or weakness occurs during treatment, notify healthcare professionals immediately and stop taking this medication. Patients with impaired liver function or a history of liver disease should have regular liver function tests before and after taking this medication, and should stop taking it if symptoms of liver damage occur. This medication can rarely cause respiratory issues such as interstitial lung disease, so consult a healthcare professional if experiencing shortness of breath or persistent cough. Blood sugar levels may rise during the use of this medication, so patients at high risk for diabetes should check their blood sugar regularly. In clinical trials and post-marketing surveillance, this medication has generally demonstrated excellent tolerability, but side effects such as headaches, indigestion, diarrhea, cold symptoms, and muscle pain have been reported. There is limited data on safety in children and adolescents, therefore its use in children under 10 years of age is not recommended. Patients taking this medication should inform other physicians when prescribed new medications and should not discontinue or alter dosages arbitrarily.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, erythema multiforme, toxic epidermal necrolysis, eosinophilia, systemic symptoms associated with drug reactions, polymorphic erythema, drug-induced liver injury, myasthenia, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, dysgeusia, ocular motility disorders, facial paresis, tremor, peripheral neuropathy, peripheral nerve paralysis, psychiatric disorders, anxiety, sleep disorders, memory impairment, amnesia, memory loss, cognitive dysfunction, confusion, interstitial lung disease, lupus erythematosus-like syndrome, rheumatic polymyalgia, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, malaise, dyspnea, cholestasis-related jaundice, hepatic steatosis, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, anorexia, vomiting, alopecia, various skin changes, lichenoid drug rash, gynecomastia, reduced libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferases, increased ALP, elevated ɤ-GT, increased bilirubin levels, thyroid dysfunction, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial edema, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from exposure to air and moisture, and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and prevents degradation.

Appearance and packaging

Appearance

White to off-white, bilaterally convex rectangular tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.